Millipore Sigma Vibrant Logo

OP16L Anti-c-ErbB2/c-Neu (Ab-4) Mouse mAb (7.16.4)

Descripción

Replacement Information

Tabla espec. clave

Species ReactivityHostAntibody Type
H, RMMonoclonal Antibody

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
OP16L-100UG
Comprobando disponibilidad...
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Frasco de vidrio 100 μg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      Solicitar precio
      OP16L-500UG
      Comprobando disponibilidad...
      Disponibilidad a confirmar
Disponibilidad a confirmar
      Ingrese cantidad 
      Suspendido
      Cantidades limitadas disponibles
      Debe confirmarse disponibilidad
        El resto: se avisará
          El resto: se avisará
          Se avisará
          Póngase en contacto con el Servicio de Atención al Cliente
          Contact Customer Service

          Frasco de vidrio 500 μg
          Recuperando precio...
          No pudo obtenerse el precio
          La cantidad mínima tiene que ser múltiplo de
          Maximum Quantity is
          Al finalizar el pedido Más información
          Ahorró ()
           
          Solicitar precio
          Description
          OverviewRecognizes the ~185 kDa c-ErbB2/c-Neu protein in overexpressing B104-1-1 cells.
          Catalogue NumberOP16L
          Brand Family Calbiochem®
          SynonymsAnti-HER2, Anti-Neu, Anti-ErbB2, Anti-Erythroblastosis Virus
          References
          ReferencesZhang, H., et al. 1999. Exp. Mol. Pathol. 67, 15.
          Peterson, N.C. and Greene, M.I., 1988. DNA Cell Biol. 17, 1031.
          Kokai, Y., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 5389.
          Van De Vijver, M.J., et al. 1988. New Engl. J. Med. 319, 1239.
          DiFiore, P.P., et al. 1987. Science 237, 178.
          Kokai, Y., et al. 1987. Proc. Natl. Acad. Sci. USA 84, 8498.
          Slamon, D.J., et al. Science 235, 177.
          Varley, J.M., et al. 1987. Oncogene 1, 423.
          Bargmann, C.I., et al. 1986. Nature 319, 226.
          Yamamoto, T., et al. 1986. Nature 319, 230.
          Blick, M., et al. 1984. Blood 64, 1234.
          Schwab, M., et al. 1984. Cold Spring Harbor Laboratory 2, 215.
          Product Information
          FormLyophilized
          FormulationLyophilized from a volatile buffer, 100 µg BSA.
          Negative controlFisher rat embryo cells
          Positive controlB104-1-1 cells
          PreservativeNone
          Quality LevelMQ100
          Applications
          Application ReferencesImmunoprecipitation Kokai, Y., et al. 1989. Cell 58, 287. Kokai, Y., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 5389. Frozen Sections Kokai, Y., et al. 1987. Proc. Natl. Acad. Sci. USA 84, 8498. Original Clone, Growth Inhibition Assays Drebin, J.A., et al. 1988. Oncogene 2, 273. Immunoblotting Montgomery, R.B., et al. 2005. Cancer Res. 65, 650.
          Key Applications Frozen Sections
          Growth Inhibition Assay
          Immunoblotting (Western Blotting)
          Immunocytochemistry
          Immunoprecipitation
          Application NotesGrowth Inhibition Assays (see application references)
          Frozen Sections (5 µg/ml, see application references)
          Immunoblotting (see application references)
          Immunocytochemistry (5 µg/ml)
          Immunoprecipitation (1 µg/ml, see application references)
          Application CommentsStains frozen tissue sections of rat cells overexpressing the c-neu protein. This antibody does not inhibit in vitro protein-tyrosine kinase activity, but it will inhibit in vivo growth of tumors overexpressing the neu oncogene (see application references). Does not cross-react with the EGF receptor. Antibody should be titrated for optimal results in individual systems.
          Biological Information
          ImmunogenB104-1-1 cells overexpressing rat c-ErbB2/c-Neu
          ImmunogenHuman
          Epitopewithin the extracellular domain
          Clone7.16.4
          HostMouse
          IsotypeIgG2a
          Species Reactivity
          • Human
          • Rat
          Antibody TypeMonoclonal Antibody
          Physicochemical Information
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          Safety Information
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Standard Handling
          Storage +2°C to +8°C
          Do not freeze Ok to freeze
          Special InstructionsReconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
          Packaging Information
          Transport Information
          Supplemental Information
          Specifications
          Global Trade Item Number
          Número de referencia GTIN
          OP16L-100UG 04055977208733
          OP16L-500UG 04055977208740

          Documentation

          Anti-c-ErbB2/c-Neu (Ab-4) Mouse mAb (7.16.4) Certificados de análisis

          CargoNúmero de lote
          OP16L

          Referencias bibliográficas

          Visión general referencias
          Zhang, H., et al. 1999. Exp. Mol. Pathol. 67, 15.
          Peterson, N.C. and Greene, M.I., 1988. DNA Cell Biol. 17, 1031.
          Kokai, Y., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 5389.
          Van De Vijver, M.J., et al. 1988. New Engl. J. Med. 319, 1239.
          DiFiore, P.P., et al. 1987. Science 237, 178.
          Kokai, Y., et al. 1987. Proc. Natl. Acad. Sci. USA 84, 8498.
          Slamon, D.J., et al. Science 235, 177.
          Varley, J.M., et al. 1987. Oncogene 1, 423.
          Bargmann, C.I., et al. 1986. Nature 319, 226.
          Yamamoto, T., et al. 1986. Nature 319, 230.
          Blick, M., et al. 1984. Blood 64, 1234.
          Schwab, M., et al. 1984. Cold Spring Harbor Laboratory 2, 215.

          Citas

          Título
        • R. Bruce Montgomery, et al. (2005) Endogenous Anti-HER2 Antibodies Block HER2 Phosphorylation and Signaling through Extracellular Signal-Regulated Kinase. Cancer Research 65, 650-656.
        • Ficha técnica

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision16-November-2007 JSW
          SynonymsAnti-HER2, Anti-Neu, Anti-ErbB2, Anti-Erythroblastosis Virus
          ApplicationGrowth Inhibition Assays (see application references)
          Frozen Sections (5 µg/ml, see application references)
          Immunoblotting (see application references)
          Immunocytochemistry (5 µg/ml)
          Immunoprecipitation (1 µg/ml, see application references)
          DescriptionPurified mouse monoclonal antibody generated by immunizing C3H mice with the specified immunogen and fusing splenocytes with NS-1 mouse myeloma cells (see application references). Recognizes the ~185 kDa c-Erb2/c-neu protein.
          BackgroundAmplification of the human proto-oncogene c-neu occurs in approximately 30% of breast carcinomas and the amplification maybe a useful predictor of disease prognosis. Gene amplification and the resulting overexpression of proto-oncogene encoded proteins is thought to transform cells by chronically stimulating signal transduction pathways and in model systems overexpression of human c-neu induces cellular transformation. In the rat model system, a point mutation has been located within the transmembrane domain of the c-neu oncogene. neu (from neuroglioblastomas) is also referred to as erbB-2 (from erythroblastosis virus) and HER2 (for Human Epidermal Growth Factor Receptor) and was the second of four members of the EGF receptor family to be described.
          HostMouse
          Immunogen speciesHuman
          ImmunogenB104-1-1 cells overexpressing rat c-ErbB2/c-Neu
          Epitopewithin the extracellular domain
          Clone7.16.4
          IsotypeIgG2a
          Specieshuman, rat
          Positive controlB104-1-1 cells
          Negative controlFisher rat embryo cells
          FormLyophilized
          FormulationLyophilized from a volatile buffer, 100 µg BSA.
          PreservativeNone
          CommentsStains frozen tissue sections of rat cells overexpressing the c-neu protein. This antibody does not inhibit in vitro protein-tyrosine kinase activity, but it will inhibit in vivo growth of tumors overexpressing the neu oncogene (see application references). Does not cross-react with the EGF receptor. Antibody should be titrated for optimal results in individual systems.
          Storage +2°C to +8°C
          Do Not Freeze Ok to freeze
          Special InstructionsReconstitute the lyophilized antibody with sterile PBS, pH 7.4, or sterile 20 mM Tris-saline (20 mM Tris containing 0.15 M NaCl), pH 7.4, to yield a final concentration of 100 µg/ml. Lyophilized antibodies should be reconstituted at 4°C with occasional gentle mixing for at least 2 h. Following reconstitution, refrigerate (4°C) for short-term storage or aliquot and freeze (-20°C) for long-term storage with 0.1% azide. Avoid freeze/thaw cycles of solutions.
          Toxicity Standard Handling
          ReferencesZhang, H., et al. 1999. Exp. Mol. Pathol. 67, 15.
          Peterson, N.C. and Greene, M.I., 1988. DNA Cell Biol. 17, 1031.
          Kokai, Y., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 5389.
          Van De Vijver, M.J., et al. 1988. New Engl. J. Med. 319, 1239.
          DiFiore, P.P., et al. 1987. Science 237, 178.
          Kokai, Y., et al. 1987. Proc. Natl. Acad. Sci. USA 84, 8498.
          Slamon, D.J., et al. Science 235, 177.
          Varley, J.M., et al. 1987. Oncogene 1, 423.
          Bargmann, C.I., et al. 1986. Nature 319, 226.
          Yamamoto, T., et al. 1986. Nature 319, 230.
          Blick, M., et al. 1984. Blood 64, 1234.
          Schwab, M., et al. 1984. Cold Spring Harbor Laboratory 2, 215.
          Citation
        • R. Bruce Montgomery, et al. (2005) Endogenous Anti-HER2 Antibodies Block HER2 Phosphorylation and Signaling through Extracellular Signal-Regulated Kinase. Cancer Research 65, 650-656.
        • Application referencesImmunoprecipitation Kokai, Y., et al. 1989. Cell 58, 287. Kokai, Y., et al. 1988. Proc. Natl. Acad. Sci. USA 85, 5389. Frozen Sections Kokai, Y., et al. 1987. Proc. Natl. Acad. Sci. USA 84, 8498. Original Clone, Growth Inhibition Assays Drebin, J.A., et al. 1988. Oncogene 2, 273. Immunoblotting Montgomery, R.B., et al. 2005. Cancer Res. 65, 650.

          Productos y aplicaciones relacionados

          Related Products

          Número de referencia Descripción  
          OP16 Anti-c-ErbB2/c-Neu (Ab-4) Mouse mAb (7.16.4) Precios y disponibilidad

          Categorías

          Life Science Research > Antibodies and Assays > Primary Antibodies